Understanding Highlights From Esmo Breast 2021
Welcome to our comprehensive guide on Highlights From Esmo Breast 2021. Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, shares her
Key Takeaways about Highlights From Esmo Breast 2021
- Javier Cortés, MD, PhD, Vall d'Hebron University Hospital, Barcelona, Spain, shares his
- Sara Hurvitz shares what she is looking forward to from the
- Dr Elisa Agostinetto joins us in Berlin to share her perspectives on the latest
- In this conference update video, Profs. Wolfgang Janni, Sherko Kümmel and Michail Ignatiadis provide key insights from the ...
- Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the monarchE and NATALEE trials, investigating CDK4/6 inhibitors ...
Detailed Analysis of Highlights From Esmo Breast 2021
Volkar Mueller, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, talks on important updates from the ... Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, Republic of Korea, discusses the Cristina Saura Manich, MD, PhD, Vall d'Hebron Institute of Oncology, Barcelona, Spain, comments on key clinical trials presented ...
Dr. Cesar Martins, Clinical Oncologist at Grupo Oncoclínicas, discusses phase II DESTINY-Breast01 study and meta-analysis that ...
In summary, understanding Highlights From Esmo Breast 2021 gives us a better perspective.